52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.76.8% up the range
Rs 836Rs 1,205
What Zydus Lifesciences does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary
Renamed from Cadila Healthcare in 2022, a few months after its subsidiary launched ZyCoV-D, the world's first plasmid DNA vaccine approved for humans, against COVID-19. It also discovered Saroglitazar, commonly cited as the first new drug taken from an Indian company's own research all the way to market, for diabetic dyslipidemia and later a liver disease called NASH.
Generic and branded formulations, active pharmaceutical ingredients, vaccines, plus consumer health and wellness products and medical devices through separate segments.
3
3Who buys it
A mix: US patients through generic drug distributors, which form its single largest market, Indian patients through branded prescriptions and consumer health products, and hospitals buying vaccines and devices.
4
4How it earns
Profit comes mainly from its North America generics business, its largest single revenue source, supplemented by branded India sales and smaller consumer and device segments. It also invests in its own new drug research, a riskier, higher-payoff bet most pure generic makers skip.
Implied vs realized volatility
This compares the volatility options are pricing (from the chain) with the volatility the stock has actually delivered. It appears once the live options chain is available.
options live in market hours
The options-implied volatility comes from the live chain, which is available during and around market hours (9:15-3:30 IST, Mon-Fri). The stock has realized 31.7% volatility over the last 30 days; the implied figure and the comparison will show when the chain is live.
ZYDUSLIFE price vs the biggest options level
The daily candles are the actual stock. The two labeled lines are the single strike with the most call open interest (a resistance level option sellers are defending) and the single strike with the most put open interest (a support level). The full breakdown across every strike is in the Open Interest Profile card below.
EOD 11 Sept
IndicatorsVolume
Loading ZYDUSLIFE price...
Options snapshot
The live stock option chain (PCR, max pain, expected move, OI) loads during and around market hours.
live in market hours
ZYDUSLIFE's live option chain - put-call ratio, max pain, expected move and open-interest walls - appears during market hours (9:15-3:30 IST, Mon-Fri). Come back when the market is open for the full options view.
Returns and valuation
Built from the company's own balance sheet and cash flow. Return on equity is the trailing twelve months of profit against the equity on the books; the balance sheet behind it is filed twice a year, not four times.
from the filing as at 2026-03-31
Market cap
Rs 1,11,686 Cr
what the whole company is priced at today
Return on equity
15.5%
profit earned on every Rs 100 of shareholders money
Price to book
4.12x
4.12 times the value on its own books
Return on assets
8.8%
profit against everything it owns
Return on capital
19.2%
EV / EBITDA
13.8x
Dividend yield
0.99%
paid out on today's price
Book value / share
Rs 272
the company's own books, per share
What it owns and what it owes
Straight from the balance sheet in the company's filing. Net debt is borrowings less cash and liquid investments, so a negative figure means it holds more cash than debt.
as at 2026-03-31
Total assets
Rs 52,407 Cr
everything the company owns
Shareholders equity
Rs 29,582 Cr
56% of what it owns is funded by its owners
Cash and equivalents
Rs 855 Cr
cash and near-cash on hand
Net debt
Rs 5,139 Cr
borrowings less cash
Debt to equity
0.40x
borrowings against the owners' money
Current ratio
1.27x
short-term assets against short-term dues
Companies file a balance sheet twice a year, not every quarter, so this is the most recent one published rather than the latest quarter.
The cash it actually made
Profit is an accounting figure; cash flow is what moved. Free cash flow is the cash from running the business less what was spent on plant and equipment, so it is what was left over to pay down debt or return to shareholders.
year to 2026-03-31
Cash from operations
Rs 2,117 Cr
cash the business itself threw off
Free cash flow
Rs -1,277 Cr
what was left after spending on the business
FCF margin
-4.7%
free cash for every Rs 100 of sales
Cash vs profit
0.41x
profit is being reported faster than cash arrives
Cash flow is reported for the year to date, so this covers the full period ending 2026-03-31 rather than a single quarter.
Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.
as of 2026-06-30
P/E (TTM)
24.9
PEG
-
EPS (TTM)
Rs 44.9
Net margin
16.1%
Rev growth YoY
+21.96%
Profit growth YoY
-34.90%
TTM revenue
Rs 28,592 Cr
TTM net profit
Rs 4,593 Cr
Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
5 years · 20 quarters
Full financial years - the long arc of the business.
Sales growth
+15.6%
a year, 3 years
Profit growth
+34.8%
a year, 3 years
Operating margin
31.2%
latest year
Sales by financial yearRs 27,148 Cr
Net profit by financial yearRs 5,124 Cr
FY225 full years · hover a yearFY26
Operating margin has gone from 21.3% to 31.2% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
Rs 983 in 2025
Paid 10 of 10 yrs
what 2025's payouts come to on Rs 1 lakh at today's price · nothing declared in the last twelve months
What each year paid, on Rs 1 lakh
286
286
313
313
313
313
223
536
268
983
16
17
18
19
20
21
22
23
24
25
2025 paid Rs 11.00 per share, about Rs 983 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 11 Sept
RSI (14) - momentum
45.6Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
48.5%Near average
today 48.5%20d avg 53.2%
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
vs 50-DMA
-1.58%
vs 200-DMA
+12.34%
1-month
-4.13%
3-month
+2.75%
1-year
+10.38%
Realized vol (30d)
31.7%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months
Insider trading data unavailable.
Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months
Announcements unavailable.
Want to test a strategy on ZYDUSLIFE?
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.